查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024511

經導管肺動脈瓣膜市場報告：按技術、原料、應用、終端用戶和地區分類（2026-2034 年）

Transcatheter Pulmonary Valve Market Size by Technology, Raw Material, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2025年全球經導管肺動脈瓣膜市場規模達1.028億美元。展望未來，IMARC Group預測，該市場將從2026年到2034年以7.35%的複合年成長率成長，到2034年達到1.983億美元。心血管疾病（CVD）發生率的上升、積極的研發活動以及人口老化是推動市場成長的主要因素。

經導管肺動脈瓣膜（TAV）是由牛、豬或人類心臟組織製成的人工瓣膜。它們廣泛用於替換漏血或狹窄的肺動脈瓣膜，改善血流，與開胸手術相比，切口更小，恢復更快。這些瓣膜透過一根細而柔軟的導管插入大血管，因此屬於微創手術。經導管肺動脈瓣膜置換術術疼痛較輕，恢復時間更短，有助於改善症狀，同時降低併發症的風險。它還有助於恢復血流，緩解主動脈瓣狹窄的徵兆和症狀，例如胸痛、呼吸困難、暈厥和疲勞。因此，這些瓣膜在心臟畸形、肺動脈瓣逆流、閉鎖、狹窄和動脈幹等疾病中有廣泛的應用。

經導管肺動脈瓣膜市場的發展趨勢：

全球各種心血管疾病（CVD）發生率的不斷上升，包括風濕性心臟疾病、高血壓性心臟疾病、腦血管疾病和發炎性心臟疾病，是推動市場成長的主要因素。此外，老年人口的成長以及與嚴重主動脈瓣狹窄、二尖瓣逆流和三尖瓣逆流相關的退化性異常的盛行率上升，也進一步促進了市場成長。同時，兒童經導管肺動脈瓣置換術（TPVR）產品應用的日益普及也推動了市場成長。這主要是由於肺動脈狹窄、肺動脈閉鎖、法洛氏四合症及其他相關疾病的發生率不斷上升，促使人們將這些產品視為有效的治療選擇。此外，人工智慧（AI）在經導管肺動脈瓣置換術（TPVR）中的應用，透過輔助術前規劃、識別風險因素以及改善診斷和臨床決策，也促進了市場成長。最後，球囊擴張技術日益成長的需求也對市場成長產生了積極影響，因為它提供了一種更快速、更簡單、更精確且結果更準確的手術流程。此外，採用鎳鈦合金製成的自膨脹式上緣主動脈瓣膜系統「Hydra主動脈瓣」的推出，也促進了市場成長。該系統能夠實現瓣膜的精準定位，並確保瓣膜部署在正確的位置。其他有望推動市場前景向好的因素包括：對創新型心臟瓣膜的需求不斷成長、高血壓患者數量增加、醫療產業的快速發展、消費者購買力的提高、廣泛的研發活動，以及政府主導的旨在開發高效經導管肺動脈瓣膜的各項舉措的實施。

本報告解答的主要問題：

  • 全球經導管肺動脈瓣膜市場迄今的發展軌跡如何？預計未來幾年將如何發展？
  • 全球經導管肺動脈瓣膜市場的促進因素、阻礙因素和機會是什麼？
  • 主要區域市場有哪些？
  • 哪個國家的經導管肺動脈瓣膜市場最具吸引力？
  • 按技術分類的市場組成是什麼？
  • 按原料分類的市場組成是什麼？
  • 按應用領域分類的市場區隔如何？
  • 依最終用戶分類的市場區隔如何？
  • 全球經導管肺動脈瓣膜市場的競爭格局如何？
  • 全球經導管肺動脈瓣膜市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球經導管肺動脈瓣膜市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依技術分類

  • 球囊擴張型經導管瓣膜
  • 自膨式經導管瓣膜

第7章 市場區隔：依原料分類

  • 組織工程
  • 合成

第8章 市場區隔：依應用領域分類

  • 法洛四部曲
  • 心臟異常
  • 肺動脈閉鎖
  • 肺動脈狹窄
  • 肺動脈瓣逆流
  • 軀幹動脈異常
  • 其他

第9章 市場區隔：依最終用戶分類

  • 成人
  • 兒童

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章：促進、抑制與機遇

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Artivion Inc.
    • Boston Scientific Corporation
    • Braile Biomedica
    • Colibri Heart Valve LLC
    • Edwards Lifesciences Corporation
    • JenaValve Technology Inc.
    • Labcor Laboratorios Ltda.
    • Medtronic plc
    • Venus Medtech（Hangzhou）Inc.
Product Code: SR112026A6954

The global transcatheter pulmonary valve market size reached USD 102.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 198.3 Million by 2034, exhibiting a growth rate (CAGR) of 7.35% during 2026-2034. The increasing incidence of various cardiovascular diseases (CVDs), extensive research and development (R&D) activities, and the rising geriatric population represent some of the key factors driving the market.

A transcatheter pulmonary valve refers to an artificial valve made from cow, pig, or human heart tissue. It is widely used to replace leaky or narrowed pulmonary valves to improve blood flow, with fewer incisions and faster recovery than open surgery. These valves are inserted through a thin, flexible tube (catheter) into a large blood vessel involving a minimally invasive (MI) procedure. Transcatheter pulmonary valve replacement involves less pain and a shorter recovery period and helps in improving symptoms while lowering the risk of medical complications. It also helps to restore blood flow and reduce the signs and symptoms of aortic valve stenosis, such as chest pain, shortness of breath, fainting, and fatigue. As a result, these valves find extensive applications in cardiac anomaly, pulmonary regurgitation, atresia, stenosis, and truncus arteriosus.

Transcatheter Pulmonary Valve Market Trends:

The rising incidences of various cardiovascular diseases (CVDs), such as rheumatic heart disorders, hypertensive heart diseases, cerebrovascular diseases, and inflammatory heart diseases across the globe, are among the key factors driving the market growth. In line with this, the rising geriatric population and increasing prevalence of degenerative abnormalities associated with severe aortic stenosis and mitral and tricuspid regurgitation are favoring the market growth. Moreover, the widespread product adoption in the treatment of pediatric transcatheter pulmonary is contributing to the market growth. This can be primarily attributed to the increasing frequency of pulmonary stenosis, atresia, tetralogy of Fallot, and other related disorders, which is facilitating the product adoption as an effective treatment option. Apart from this, the integration of artificial intelligence (AI) in the transcatheter pulmonary valve replacement (TPVR) procedure, as it assists in pre-procedural planning, identifying risk factors, and enhancing diagnosis and clinical decision-making, is providing an impetus to the market growth. Additionally, the increasing demand for balloon-expanded technology as it involves a faster and simpler process and offers high accuracy and precision of the result is positively influencing the market growth. Besides this, the launch of the hydra aortic valve, which is a self-expanding supra-annular aortic system made of nitinol that allows precise placement of the valve and ensures orthotopic deployment, is propelling the market growth. Other factors, including growing demand for innovative heart valves, an increasing number of hypertension cases, escalating growth in the healthcare industry, rising expenditure capacities of consumers, extensive research and development (R&D) activities, and the implementation of various government initiatives to develop efficient transcatheter pulmonary valves, are anticipated to create a positive outlook for the market.

Key Market Segmentation:

This report provides an analysis of the key trends in each segment of the global transcatheter pulmonary valve market, along with forecasts at the global, regional, and country level from 2026-2034. The report has categorized the market based on technology, raw material, application, and end user.

Technology Insights:

  • Balloon-Expanded Transcatheter Valve
  • Self-Expanded Transcatheter Valve

Raw Material Insights:

  • Tissue Engineered
  • Synthetic

Application Insights:

  • Tetralogy of Fallot
  • Cardiac Anomaly
  • Pulmonary Atresia
  • Pulmonary Stenosis
  • Pulmonary Regurgitation
  • Truncus Arteriosus
  • Others

End User Insights:

  • Adult
  • Pediatric

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others);Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for transcatheter pulmonary valve. Some of the factors driving the North America transcatheter pulmonary valve market included the rising geriatric population, growing demand for innovative heart valves, and various technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global transcatheter pulmonary valve market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Artivion Inc., Boston Scientific Corporation, Braile Biomedica, Colibri Heart Valve LLC, Edwards Lifesciences Corporation, JenaValve Technology Inc., Labcor Laboratorios Ltda., Medtronic plc, Venus Medtech (Hangzhou) Inc., etc.

Key Questions Answered in This Report:

  • How has the global transcatheter pulmonary valve market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global transcatheter pulmonary valve market?
  • What are the key regional markets?
  • Which countries represent the most attractive transcatheter pulmonary valve markets?
  • What is the breakup of the market based on technology?
  • What is the breakup of the market based on the raw material?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What is the competitive structure of the global transcatheter pulmonary valve market?
  • Who are the key players/companies in the global transcatheter pulmonary valve market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transcatheter Pulmonary Valve Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Balloon-Expanded Transcatheter Valve
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Self-Expanded Transcatheter Valve
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Raw Material

  • 7.1 Tissue Engineered
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Synthetic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Tetralogy of Fallot
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiac Anomaly
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Pulmonary Atresia
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pulmonary Stenosis
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Pulmonary Regurgitation
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Truncus Arteriosus
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Adult
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Pediatric
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Artivion Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Boston Scientific Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Braile Biomedica
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Colibri Heart Valve LLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Edwards Lifesciences Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 JenaValve Technology Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Labcor Laboratorios Ltda.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Medtronic plc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Venus Medtech (Hangzhou) Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials

List of Figures

  • Figure 1: Global: Transcatheter Pulmonary Valve Market: Major Drivers and Challenges
  • Figure 2: Global: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Transcatheter Pulmonary Valve Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Transcatheter Pulmonary Valve Market: Breakup by Raw Material (in %), 2025
  • Figure 6: Global: Transcatheter Pulmonary Valve Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Transcatheter Pulmonary Valve Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Transcatheter Pulmonary Valve Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Transcatheter Pulmonary Valve (Balloon-Expanded Transcatheter Valve) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Transcatheter Pulmonary Valve (Balloon-Expanded Transcatheter Valve) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Transcatheter Pulmonary Valve (Self-Expanded Transcatheter Valve) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Transcatheter Pulmonary Valve (Self-Expanded Transcatheter Valve) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Transcatheter Pulmonary Valve (Tissue Engineered) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Transcatheter Pulmonary Valve (Tissue Engineered) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Transcatheter Pulmonary Valve (Synthetic) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Transcatheter Pulmonary Valve (Synthetic) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Transcatheter Pulmonary Valve (Tetralogy of Fallot) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Transcatheter Pulmonary Valve (Tetralogy of Fallot) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Transcatheter Pulmonary Valve (Cardiac Anomaly) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Transcatheter Pulmonary Valve (Cardiac Anomaly) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Transcatheter Pulmonary Valve (Pulmonary Atresia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Transcatheter Pulmonary Valve (Pulmonary Atresia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Transcatheter Pulmonary Valve (Pulmonary Stenosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Transcatheter Pulmonary Valve (Pulmonary Stenosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Transcatheter Pulmonary Valve (Pulmonary Regurgitation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Transcatheter Pulmonary Valve (Pulmonary Regurgitation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Transcatheter Pulmonary Valve (Truncus Arteriosus) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Transcatheter Pulmonary Valve (Truncus Arteriosus) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Transcatheter Pulmonary Valve (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Transcatheter Pulmonary Valve (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Transcatheter Pulmonary Valve (Adult) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Transcatheter Pulmonary Valve (Adult) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Transcatheter Pulmonary Valve (Pediatric) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Transcatheter Pulmonary Valve (Pediatric) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: North America: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: North America: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: United States: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: United States: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Canada: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Canada: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Asia-Pacific: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Asia-Pacific: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: China: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: China: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Japan: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Japan: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: India: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: India: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: South Korea: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: South Korea: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Australia: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Australia: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Indonesia: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Indonesia: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Others: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Others: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Europe: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Europe: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Germany: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Germany: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: France: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: France: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: United Kingdom: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: United Kingdom: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Italy: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Italy: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Spain: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Spain: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Russia: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Russia: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Latin America: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Latin America: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Brazil: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Brazil: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Mexico: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Mexico: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Others: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Others: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Middle East and Africa: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Middle East and Africa: Transcatheter Pulmonary Valve Market: Breakup by Country (in %), 2025
  • Figure 83: Middle East and Africa: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Global: Transcatheter Pulmonary Valve Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Transcatheter Pulmonary Valve Industry: Value Chain Analysis
  • Figure 86: Global: Transcatheter Pulmonary Valve Industry: Porter's Five Forces Analysis

List of Tables

  • Table 2: Global: Transcatheter Pulmonary Valve Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 3: Global: Transcatheter Pulmonary Valve Market Forecast: Breakup by Raw Material (in Million USD), 2026-2034
  • Table 4: Global: Transcatheter Pulmonary Valve Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Transcatheter Pulmonary Valve Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Transcatheter Pulmonary Valve Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Transcatheter Pulmonary Valve Market: Competitive Structure
  • Table 8: Global: Transcatheter Pulmonary Valve Market: Key Players